VRML - Vermillion, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
1.49
-0.02 (-1.32%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close1.51
Open1.52
Bid0.00 x 0
Ask0.00 x 0
Day's Range1.46 - 1.53
52 Week Range0.76 - 2.85
Volume8,726
Avg. Volume49,136
Market Cap83.68M
Beta1.87
PE Ratio (TTM)-6.93
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube19 days ago

    ETFs with exposure to Vermillion, Inc. : October 2, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Vermillion, Inc. Here are 5 ETFs with the largest exposure to VRML-US. Comparing the performance and risk of Vermillion, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Is It Too Late To Buy Vermillion Inc (VRML)?
    Simply Wall St.last month

    Is It Too Late To Buy Vermillion Inc (VRML)?

    Vermillion Inc (NASDAQ:VRML), a healthcare equipment and services company based in United States, saw a double-digit share price rise of over 10% in the past couple of months on theRead More...

  • Capital Cubelast month

    ETFs with exposure to Vermillion, Inc. : September 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Vermillion, Inc. Here are 5 ETFs with the largest exposure to VRML-US. Comparing the performance and risk of Vermillion, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Vermillion, Inc. :VRML-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
    Capital Cubelast month

    Vermillion, Inc. :VRML-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017

    Categories: Yahoo FinanceGet free summary analysis Vermillion, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Vermillion, Inc. – OraSure Technologies, Inc., Quest Diagnostics Incorporated, Akers Biosciences, Inc., Chembio Diagnostics, Inc., Foundation Medicine, Inc., Biocept, Inc., Myriad Genetics, Inc. and Quidel Corporation (OSUR-US, DGX-US, AKER-US, ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of VRML earnings conference call or presentation 9-Aug-17 8:30pm GMT

    Q2 2017 Vermillion Inc Earnings Call

  • Associated Press2 months ago

    Vermillion reports 2Q loss

    On a per-share basis, the Austin, Texas-based company said it had a loss of 4 cents. The diagnostic and bio-analytical company posted revenue of $898,000 in the period. In the final minutes of trading ...

  • Capital Cube3 months ago

    ETFs with exposure to Vermillion, Inc. : July 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Vermillion, Inc. Here are 5 ETFs with the largest exposure to VRML-US. Comparing the performance and risk of Vermillion, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of VRML earnings conference call or presentation 11-May-17 12:30pm GMT

    Q1 2017 Vermillion Inc Earnings Call

  • Capital Cube5 months ago

    ETFs with exposure to Vermillion, Inc. : May 15, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Vermillion, Inc. Here are 5 ETFs with the largest exposure to VRML-US. Comparing the performance and risk of Vermillion, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Vermillion, Inc. :VRML-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017
    Capital Cube5 months ago

    Vermillion, Inc. :VRML-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017

    Categories: Yahoo FinanceGet free summary analysis Vermillion, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Vermillion, Inc. – OraSure Technologies, Inc., Quest Diagnostics Incorporated, Chembio Diagnostics, Inc., Foundation Medicine, Inc., Myriad Genetics, Inc. and Quidel Corporation (OSUR-US, DGX-US, CEMI-US, FMI-US, MYGN-US and QDEL-US) that ... Read more (Read more...)

  • Associated Press5 months ago

    Vermillion reports 1Q loss

    The Austin, Texas-based company said it had a loss of 5 cents per share. The diagnostic and bio-analytical company posted revenue of $726,000 in the period. The company's shares closed at $1.76. A year ...

  • Capital Cube7 months ago

    ETFs with exposure to Vermillion, Inc. : April 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Vermillion, Inc. Here are 5 ETFs with the largest exposure to VRML-US. Comparing the performance and risk of Vermillion, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Vermillion, Inc. :VRML-US: Earnings Analysis: Q4, 2016 By the Numbers : April 3, 2017
    Capital Cube7 months ago

    Vermillion, Inc. :VRML-US: Earnings Analysis: Q4, 2016 By the Numbers : April 3, 2017

    Categories: Yahoo Finance Get free summary analysis Vermillion, Inc. reports financial results for the quarter ended December 31, 2016. Highlights Summary numbers: Revenues of USD 0.81 million, Net Earnings of USD -2.85 million. Gross margins widened from -34.90% to 4.84% compared to the same period last year, operating (EBITDA) margins now -326.96% from -1,357.89%. Change in operating cash ... Read more (Read more...)

  • Thomson Reuters StreetEvents7 months ago

    Edited Transcript of VRML earnings conference call or presentation 29-Mar-17 8:30pm GMT

    Q4 2016 Vermillion Inc Earnings Call

  • Associated Press7 months ago

    Vermillion reports 4Q loss

    The Austin, Texas-based company said it had a loss of 5 cents per share. The diagnostic and bio-analytical company posted revenue of $805,000 in the period. For the year, the company reported that its ...

  • Is Rentech, Inc. (RTK) A Good Stock To Buy According To Hedge Funds?
    Insider Monkey10 months ago

    Is Rentech, Inc. (RTK) A Good Stock To Buy According To Hedge Funds?

    Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap stocks and pouring cash into these candidates. Small-cap stocks are overlooked by most investors, brokerage houses, and financial services hubs, while the unlimited research abilities of the big players […]

  • Capital Cube10 months ago

    ETFs with exposure to Vermillion, Inc. : December 9, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Vermillion, Inc. Here are 5 ETFs with the largest exposure to VRML-US. Comparing the performance and risk of Vermillion, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)